Next Article in Journal
Targeted Neurotransmitters Profiling Identifies Metabolic Signatures in Rat Brain by LC-MS/MS: Application in Insomnia, Depression and Alzheimer’s Disease
Previous Article in Journal
Expression of Bioactive Lunasin Peptide in Transgenic Rice Grains for the Application in Functional Food
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and Antisense Properties of 2′β-F-Arabinouridine Modified Oligonucleotides with 4′-C-OMe Substituent

1
Beijing Institute of Radiation Medicine, Beijing 100850, China
2
School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2018, 23(9), 2374; https://doi.org/10.3390/molecules23092374
Submission received: 27 August 2018 / Revised: 11 September 2018 / Accepted: 12 September 2018 / Published: 17 September 2018

Abstract

:
A novel 2′-F,4′-C-OMe–arabinouridine (araU) was successfully synthesized and introduced into oligonucleotides. The oligonucleotide containing 2′-F,4′-C-OMe–araU exhibited improved nuclease resistance and RNA hybridizing selective ability relative to 2′-F–araU. In particular, when 2′-F,4′-C-OMe–araU inserted into C–H⋯F–C bonding-favorable 5′–uridine–purine–3′ steps, the modified oligonucleotide showed remarkable binding affinity and selectivity to RNA complements. Thus, 2′-F,4′-C-OMe–araU has valuable antisense properties and can be used as novel chemical modification for antisense therapeutic strategy.

Graphical Abstract

1. Introduction

Chemical modification is essential to the efficient therapeutic application of antisense oligonucleotides. However, research on novel chemically modified nucleotides with optimal binding affinity, nuclease stability, and other desired oligonucleotides properties is still necessary [1,2,3]. Among numerous modifications available to date, fluorinated nucleotide derivatives are intensively investigated and play a privileged role in oligonucleotides [4,5,6]. Fluorine is small, with size similar to that of hydrogen; however, due to its higher electronegativity and low polarizability, fluorine can profoundly impact physicochemical and biological properties, such as hydrogen bonding, stability, and lipophilicity [7,8]. Specifically, fluorinated modification on the sugar moiety of the nucleotides can pre-organize sugar puckering, and this behavior is closely related to the binding affinity of oligonucleotides [8,9,10,11].
Thereof, as a simple and obvious fluorinated nucleotide on the sugar ring, 2′-deoxy-2′-fluoroarabinonucleic acid (2′-F–ANA) is widely applied in antisense, small interfering RNA (siRNA), riboenzyme, micro RNA (miRNA), aptamer-based oligonucleotides [12]. Once incorporated into the DNA strand of DNA–RNA hybrids, 2′-F–ANA can lead to an increase in the binding affinity compared to its 2′-OH congeners. Nevertheless, this thermal stabilizing effect is largely attributed to the formation of the C–H⋯F–C pseudohydrogen bonds between 2′F and purine H8 of the 3′-proximal nucleotide at 5′–pyrimidine–purine–3′ steps, where the base-stacking geometry is pre-organized to optimize the interaction without incurring unfavorable contacts [9,13,14]. In addition, unlike its epimeric 2′α-F–RNA, 2′-F–ANA is a DNA mimic. The presence of 2′β-F is believed to promote an [O4′–C1′–C2′–F2′] gauche interaction to steer the sugar puckers toward the C2′-endo/C4′-endo (southeast) conformation. Nevertheless, 2′-F–ANA can be sufficiently flexible to adopt a preferred north conformation due to the limited steric interactions of the fluorine atom. Moreover, 2′-F–ANA is found to be generally more stable to snake venom phosphodiesterase (SVPDE) than corresponding DNA and 2′-F–RNA [12]. Inspired by these intriguing features of 2′-F–ANA, we set out to design a series of 2′-F–ANA-based chemically modified nucleotides.
We chose to introduce an alkoxy group into the C4′-position of 2′-F–ANA, thus designing a novel bifunctional 4′-C-alkoxy-2′-F–arabinonucleotide derivative as presented in Figure 1. It is reported that the strong anomeric effect of the exocyclic oxygen atom attached to the C4′ carbon can drive the sugar part of 2′-deoxynucleotides toward the RNA-like C3′-endo (north) conformation. This conformational behavior is highly beneficial to the binding affinity to complementary RNA [15,16]. Moreover, Damha et al. [17] demonstrated that introduction of 4′-F into 2′-F–araU switched the preferred sugar conformation from DNA-like to RNA-like by the similar anomeric effect of 4′-F. Hence, it was predicted that the 4′-C-alkoxy-2′-F–arabinonucleotide derivatives would also pre-organize the sugar ring toward a north conformation, and enhance the hybridization properties for antisense oligonucleotides. Moreover, C4′ modifications on the ribose moiety, such as 4′-S [11], 4′-C-OMe [15,16], and 4′-C-aminomethyl [10,18], are reliable strategies to increase nuclease resistance. In particular, the C4′-modified 2′-F–uridine derivative, 2′-F,4′-Cα-OMe–uridine, which was recently reported by Damha et al. [19], was able to increase nuclease resistance due to the close proximity between 4′-OMe substituent and the vicinal 5′- and 3′-phosphate group. Thus, we anticipated that the 4′-C-alkoxy-2′-F–arabinonucleotide derivative would retain the C–H⋯F–C pseudohydrogen bonding ability, and, despite the sugar puckering changes, would improve the therapeutic properties relative to 2′-F–ANA.
Aiming to develop the 4′-C-alkoxy-2′-F–arabinonucleotide derivative for antisense application, we previously constructed and evaluated a bifunctional modification 2′-deoxy-2′-F,4′-C-(2-methoxyethoxy)–arabinouridine (2′-F,4′-C-MOE–araU) [20]. We found that the oligonucleotides modified with 2′-F,4′-C-MOE–araU, especially in the context of C–H⋯F–C bonding-favorable 5′–uridine–purine–3′ steps, showed significant RNA selectivity and duplex stability when hybridized to RNA complements. This finding suggested that combination of 4′-C-alkoxy modification and pseudohydrogen bond of 2′β-F is compatible. However, 2′-F,4′-C-MOE–araU at the 3′-terminal of the oligonucleotide was found to decrease nuclease resistance ability compared to corresponding 2′-F–araU. These results prompted us to develop novel 4′-C-alkoxy substituents to further explore the potential of 2′-F–ANA. Herein, we report the synthesis and antisense properties of 2′-deoxy-2′-F,4′-C-methoxy arabinouridine (2′-F,4′-C-OMe–araU) as a novel 2′-F–ANA derivative with C4′-methoxy substitution.

2. Results and Discussion

2.1. Chemistry

The synthesis of the 2′-F,4′-C-OMe–araU derivative was performed as depicted in Scheme 1. According to the reported method [21], treatment of 2′-F–araU 1 with I2/Ph3P in tetrahydrofuran (THF), followed by elimination with sodium methoxide (NaOMe) in methanol, readily generated the 4′-methylene 3. Treatment of 3 with iodine/methanol in the presence of PbCO3 yielded the 4′-methoxy analog 4; in this preparation, the 4′-OMe substituent was introduced by opening the transient iodonium ion of 4′-methylene nucleoside 3 with methanol (MeOH) in a regio- and stereo-specific manner. Benzoylation of 4, followed by treatment with m-chloroperbenzoic acid (m-CPBA) in water-saturated dichloromethane and subsequent hydrolysis in NH3–MeOH afforded the target nucleoside monomer, 2′-F,4′-C-OMe–araU 6. Next, the treatment of 6 with dimethoxytrityl chloride (DMTrCl) in pyridine generated tritylated 7. Then, phosphitylation of 7 with 2-cyanoethyl N,N,N′,N′-tetraisopropylphosphoramidite in the presence of 1H-tetrazole gave phosphoramidite 8 as a standard building block for automated oligonucleotide synthesis. Finally, 8 was incorporated into oligonucleotides on an automated DNA synthesizer using 5-ethylthio-1H-tetrazole as an activator with a prolonged coupling time of 6 min. After cleavage from the solid support and deprotection, all corresponding sequences were purified by reversed-phase (RP) HPLC chromatography and validated by mass spectrometry (Supplementary Materials, Table S1).

2.2. Hybridization Properties

The duplex-forming abilities of 2′-F,4′-C-OMe–araU and 2′-F–araU modified oligonucleotides with their complementary single-stranded RNA and DNA (ssRNA and ssDNA) were evaluated by ultraviolet (UV)-thermal denaturation experiments and their properties were compared with those of the corresponding natural DNA. As can be seen in Table 1, the melting temperature (Tm) value of the 2′-F,4′-C-OMe–araU modified oligonucleotide 2 (ON2)–RNA hybrid was found to be slightly higher than that of the 2′-F–araU modified ON3–RNA hybrid when inserted at the same position of the oligonucleotides. In contrast, the thermal stability of the duplex formed by ON2 with the DNA complement was lower than that of ON3–DNA hybrid. As a result, in ON2 and ON3, the differences in ΔTm values with RNA (ΔTm (RNA)) and DNA (ΔTm (DNA)) were +2.8 °C and −0.7 °C, respectively. Thus, 2′-F,4′-C-OMe–araU modified ON2 had enhanced RNA selectivity relative to 2′-F–araU. In addition, the 2′-F,4′-C-OMe–araU modification contributed to RNA selectivity in ON45, ON78, and ON1011. Since the RNA-selective hybridization ability was highly related to the conformational preorganization of the sugar, we investigated the 1H–1H J-coupling constants of H2″/H3′ and H1′/F2′ to determine the sugar conformation. According to the Karplus equation’s prediction [17], a northern conformer will have a large 3JH2″H3′ coupling constant, whereas a southern conformer will have a large 3JH1′F2′ value. The experimental 3JH2″H3′ and 3JH1′F2′ values of 2′-F,4′-C-OMe–araU in D2O were 5.6 and 9.0 Hz, respectively, whereas those for 2′-F–araU were 3.0 and 17.5 Hz, respectively (Supplementary Materials, Table S2). These data indicated the high preference for north pucker in 2′-F,4′-C-OMe–araU, as previously predicted. Therefore, we concluded that the 4′-C-OMe in 2′-F,4′-C-OMe–araU was able to overcome the gauche effect of the 2′βF, which generally steers the sugar pucker toward a southeast conformation, and able to impart the conformation preference toward the north pucker through the strong anomeric effect. This interaction improves the hybridization property of the modified oligonucleotides. Moreover, the circular dichroism (CD) spectra showed that oligonucleotides with either single or multiple 2′-F,4′-C-OMe–araU modifications (ON2, ON45) were able to form canonical A-form duplexes with the RNA complement (Figure 2), suggesting that the conformation pre-organization on the arabino-sugar, induced by C4′-OMe substitution, would facilitate the duplex-forming ability to the RNA complement, which would exert a positive effect on the binding affinity of antisense oligonucleotides.
However, the formation of modified oligonucleotides with double or triple 2′-F,4′-C-OMe–araU led to significant duplex destabilization. The Tm values of oligonucleotides ON4 and ON5 were lower than those of natural DNA ON1 after hybridization to both RNA and DNA complements. Since the 2′-F,4′-C-OMe–araU sugar puckering prefers the north conformation, it is likely that this would lead to an unfavorable inter-nucleoside contact between 2′F and the C5 methyl group of the 3′-adjacent thymidine, and result in a destabilization effect on the duplex formation. Therefore, the hybridization ability of ON4 and ON5 with those RNA and DNA complements is decreased due to the repulsive interaction between 2′F and the C5 methyl group of the 3′-adjacent thymidine, although the conformation pre-organization of the sugar is beneficial to duplex formation. On the other hand, considering that the thermal stabilizing effect of 2′-F–ANA is largely attributed to the C–H⋯F–C pseudohydrogen bonding interaction with the 3′-adjacent purine, to further assess the impact of 2′-F,4′-C-OMe–araU modification, we designed oligonucleotides ON78 and ON1011 with a purine nucleotide (G or A) in the center of the sequence and flanked with the 2′-F,4′-C-OMe–araU monomer on either the 5′- or 3′-position of the central purine, respectively. As shown in Table 1, in the case of 2′-F,4′-C-OMe–araU modified ON7 and ON10 with preferable 5′–uridine–purine–3′ steps (XG and XA, respectively), the Tm values of duplexes formed with RNA complements were substantially higher than those of the duplexes formed by the natural DNAs ON6 and ON9 with RNA complements; the corresponding ΔTm values were 1.6 °C and 2.6 °C. In contrast, ON8 and ON11, whose 2′-F,4′-C-OMe–araU modifications were located at the 3′-proximity of the central purine, showed a destabilizing effect when hybridized to RNA complements relative to their counterpart natural DNA–RNA duplexes. These results clearly illustrated that the C–H⋯F–C pseudohydrogen bonding interaction at the favorable 5′–pyridimine–purine–3′ step exerted a remarkably stabilizing effect on the RNA complement. Additionally, compared with the hybridization ability of ON7 and ON10 with their DNA complements, 2′-F,4′-C-OMe–araU modification at the 5′–uridine–purine–3′ steps showed higher RNA selectivity than those of ON2, ON8, and ON11. The respective differences of ΔTm values with RNA (ΔTm (RNA)) and with DNA (ΔTm (DNA)) were within the range 5–6 °C. Generally, 2′βF in 2′-F,4′-C-OMe–araU was still capable of forming a pseudohydrogen bonding interaction with purine at the 5′–uridine–purine–3′ steps, which remarkably increased the binding affinity, despite the change in sugar conformation.

2.3. Nuclease Stability

The nuclease stability of the T-decamer oligonucleotide ON12 containing 2′-F,4′-C-OMe–araU at the second position of the 3′-terminus was investigated using snake venom phosphodiesterase (SVPDE) as a 3′-exonuclease, and was then compared with that of 2′-F–araU modified, 3′-phophorothioate-T and natural oligonucleotides, ON13ON15 (Figure 3). Under the conditions used in this experiment, approximately 75% oligonucleotide ON12 was still retained after 40 min of incubation. As a result, the 2′-F,4′-C-OMe–araU modification provided greater stability toward the 3′-exonuclease compared to corresponding 2′-F–araU modified ON13 and the unmodified ON15. Since the increased nuclease resistance was associated mainly with the close vicinity of the hydrophobic moiety and neighboring phosphates [19], it appeared that the 4′-C-OMe substituent was the ideal group for promoting the nuclease resistance ability of 2′-F–ANA.

3. Conclusions

In conclusion, a novel 2′-F,4′-C-OMe–araU was successfully synthesized and incorporated into oligonucleotides. The modified oligonucleotides showed enhanced RNA-selective hybridizing ability relative to 2′-F–araU due to the switch of sugar pucker. It is noteworthy that whether single- or multi-modified, these oligonucleotides could form a typical A conformation with complementary RNA. Meanwhile, the impact of 2′-F,4′-C-OMe–araU on duplex thermal stability was sequence-dependent, and oligonucleotides with C–H⋯F–C bonding-favorable 5′–uridine–purine–3′ steps had the strongest binding affinity to ssRNA. In addition, the stability against nuclease degradation of the oligonucleotides containing 2′-F,4′-C-OMe–araU was greater than that of those containing 2′-F–araU. These investigations revealed that the introduction of 4′-C-OMe into 2′-F–araU had synergistic effects on hybridization ability with ssRNA and the nuclease resistance, suggesting that 2′-F,4′-C-OMe–araU has valuable antisense properties and can be reasonably applied in the development of antisense oligonucleotides.

4. General Experimental Procedure

All chemical reagents were commercially available and used without any further purification unless otherwise mentioned. Anhydrous dichloromethane (DCM), tetrahydrofuran (THF), pyridine (Pyr), and acetonitrile (ACN) were distilled from CaH2. Reactions involving air and/or those that were moisture-sensitive were performed under nitrogen atmosphere, and the reaction process was monitored by analytical thin-layer chromatography (TLC; silica gel GF254). Flash-column chromatography was carried out with Teledyne Isco Combiflash Rf200 purification (Teledyne Isco Inc., Lincoln, NE, USA). 1H-NMR (400 MHz), 19F-NMR (376 MHz), and 31P-NMR (162 MHz) were recorded on a JEOL JNM-ECA-400 spectrometer (JOEL Ltd., Tokyo, Japan) with tetramethylsilane as the internal standard for 1H-NMR spectra, and CFCl3 and 85% H3PO4 as the external standard for 19F-NMR and 31P-NMR spectra, respectively. Mass spectra of small molecules were measured on an Agilent 1260-G6230A mass spectrometer (Agilent Technologies Inc., Santa Clara, CA, USA), mass spectra of oligonucleotides were recorded on a Bruker Daltonics UltraflexTM MALDI-TOF/TOF spectrometer (Bruker Daltonics Inc., Billerica, MA, USA) or a Thermo-Finnigan liquid chromatography quadrupole (LCQ) Ion Trap spectrometer (Thermo Fisher Scientific Inc., MA, USA). Circular dichroism (CD) spectra were performed on a Bio-logic MOS-450 CD spectrometer (Bio-Logic Inc., Claix, France). UV melting experiments were carried out on a SHIMADZU UV-1800 spectrometer (Shimadzu Corp., Kyoto, Japan) equipped with a Tm analysis accessory.

4.1. Chemistry

4.1.1. 2′,5′-Dideoxy-5′-iodo-2′-fluoro-β-d-arabinouridine (2)

To a mixture of 2′-F–araU 1 (10.0 g, 40.62 mmol), Ph3P (15.98 g, 60.93 mmol) and imidazole (5.53 g, 81.24 mmol) in 200 mL on THF were added dropwise to a solution of I2 (15.42 g, 60.93 mmol) in 100 mL of THF. After addition, the reaction mixture was stirred at room temperature for 4 h. Saturated Na2SO3 solution was added, and the mixture was extracted with ethyl acetate (EtOAc), washed with water and brine, and dried with Na2SO4. After concentration in vacuo, the residue was purified by flash chromatography (gradient eluent: MeOH/DCM, 0–10% v/v) to afford the 5′-iodination compound 2 as a pale-yellow solid, yield 78%. 1H-NMR (400 MHz, CD3OD) δ 7.71 (dd, J = 8.1, 1.9 Hz, 1H, H-6), 6.21 (dd, J = 20.0, 3.4 Hz, 1H, H-1′), 5.71 (d, J = 8.1 Hz, 1H, H-5), 5.02 (ddd, J = 51.8, 3.4, 1.8 Hz, 1H, H-2′), 4.29 (ddd, J = 17.3, 3.2, 1.8 Hz, 1H, H-3′), 3.99 (td, J = 6.2, 3.4 Hz, 1H, H-4′), 3.55–3.43 (m, 2H, H-5′); electrospray ionization (ESI)-MS (m/z) 357.1 [M + H]+.

4.1.2. 2′,5′-Dideoxy-2′-fluoro-4′-methylene-β-d-arabinouridine (3)

To a solution of compound 2 (11.5 g, 32.31 mmol) in 100 mL of MeOH, 50% NaOMe (13.96 g, 129.24 mmol) was added under nitrogen atmosphere. The reaction mixture was then heated to reflux for 4 h. After cooling to room temperature, the reaction mixture was neutralized with acetic acid (HOAc) to pH 7–8, After the removal of solvent in vacuo, the residue was purified by flash chromatography (gradient eluent: MeOH/DCM, 0–10% v/v) to afford the 4′-methylene 3 as a white solid, yield 85%. 1H-NMR (400 MHz, CD3OD) δ 7.47 (dd, J = 8.2, 2.1 Hz, 1H, H-6), 6.51 (dd, J = 19.5, 3.2 Hz, 1H, H-1′), 5.72 (d, J = 8.2 Hz, 1H, H-5), 5.11–4.96 (m, 1H, H-2′), 4.73–4.63 (m, 2H, H-3′ and =CH2), 4.47 (d, J = 2.3 Hz, 1H, =CH2); ESI-MS (m/z) 229.2 [M + H]+.

4.1.3. 2′,5′-Dideoxy-2′-fluoro-5′-iodo-4′-C-methoxy-β-d-arabinouridine (4)

To a mixture of compound 3 (2.8 g, 12.27 mmol) in 100 mL of THF, PbCO3 (6.78 g, 24.54 mmol) and anhydrous MeOH (10 mL) were successively added; a solution of I2 (6.23 g, 24.54 mmol) in 50 mL of THF was added dropwise at 0 °C. After addition, the reaction mixture was slowly warmed to room temperature and stirred for 3 h, quenched with saturated Na2SO3 solution, and filtrated with kieselguhr. The filtrate was extracted with EtOAc, washed with water and brine, dried over Na2SO4, and concentrated in vacuo. The residue was purified by flash chromatography (gradient eluent: MeOH/DCM, 0–10% v/v) to afford compound 4 as a white solid, yield 90%. 1H-NMR (400 MHz, CD3OD) δ 7.72 (dd, J = 8.2, 1.7 Hz, 1H, H-6), 6.26 (dd, J = 12.0, 5.3 Hz, 1H, H-1′), 5.74 (d, J = 8.2 Hz, 1H, H-5), 5.21–5.03 (m, 1H, H-2′), 4.55 (dd, J = 24.7, 4.5 Hz, 1H, H-3′), 3.80 (d, J = 11.5 Hz, 1H, Ha-5′), 3.54 (d, J = 11.6 Hz, 1H, Hb-5′), 3.41 (s, 3H, –OCH3); ESI-MS (m/z) 385.0 [M − H].

4.1.4. 3′-O-Benzoyl-2′,5′-dideoxy-2′-fluoro-5′-iodo-4′-C-methoxy-β-d-arabinouridine (5)

To a solution of compound 4 (2.4 g, 6.22 mmol) and pyridine (1 mL, 12.6 mmol) in 30 mL of anhydrous CH2Cl2, benzoyl chloride (856 μL, 7.46 mmol) was added dropwise at 0 °C; then, the reaction mixture was warmed slowly to room temperature and stirred for 3 h. The reaction was then quenched with water and extracted with CH2Cl2, washed with water and brine, dried over MgSO4, and concentrated in vacuo. The residue was then purified by flash chromatography (gradient eluent: MeOH/DCM, 0–10% v/v) to afford the 3′-O-benzoylation 5 as a white powder, yield 95%. 1H-NMR (400 MHz, CDCl3) δ 8.71 (s, 1H, NH), 8.12–8.05 (m, 2H, o-Ar-H), 7.70 (dd, J = 8.2, 2.2 Hz, 1H, H-6), 7.63 (t, J = 7.4 Hz, 1H, p-Ar-H), 7.49 (t, J = 7.7 Hz, 2H, m-Ar-H), 6.41 (dd, J = 15.3, 4.7 Hz, 1H, H-1′), 5.87 (m, 2H, H-5 and H-3′), 5.44 (ddd, J = 52.9, 4.6, 3.0 Hz, 1H, H-2′), 3.81 (d, J = 11.2 Hz, 1H, Ha-5′), 3.59 (d, J = 11.2 Hz, 1H, Hb-5′), 3.38 (s, 3H, –OCH3); ESI-MS (m/z) 512.99 [M + Na]+.

4.1.5. 2′-Deoxy-2′-fluoro-4′-C-methoxy-β-d-arabinouridine (6)

To a solution of compound 5 (2.19 g, 4.46 mmol) in 60 mL/15 mL of DCM/H2O (4/1, v/v), 85% m-CPBA (3.08 g, 17.83 mmol) was added in portions at 0 °C. The reaction mixture was slowly warmed to room temperature and stirred for 12 h. After the completion monitored by TLC, the reaction was quenched with saturated Na2SO3 solution and extracted with CH2Cl2, washed with saturated NaHCO3 solution and brine, dried over MgSO4, and concentrated in vacuo. The residue was directly added to excess NH3–MeOH solution (20 mL) without purification, and the reaction mixture was stirred at room temperature for 12 h. The resulting mixture was concentrated in vacuo and purified by flash chromatography (gradient eluent: MeOH/DCM, 0–15% v/v) to afford compound 6 as a white solid, yield 64%. 1H-NMR (400 MHz, D2O) δ 7.68 (dd, J = 8.1, 1.3 Hz, 1H, H-6), 6.31 (dd, J = 9.0, 5.8 Hz, 1H, H-1′), 5.80 (d, J = 8.1 Hz, 1H, H-5), 5.24 (dt, J = 54.0, 5.7 Hz, 1H, H-2′), 4.52 (dd, J = 24.0, 5.6 Hz, 1H, H-3′), 3.84 (dd, J = 12.6, 1.2 Hz, 1H, Ha-5′), 3.72 (d, J = 12.6 Hz, 1H, Hb-5′), 3.32 (s, 3H, –OCH3); ESI-MS (m/z) 299.07 [M + Na]+.

4.1.6. 2′-Deoxy-2′-fluoro-5′-O-(4,4′-dimethoxy)trityl-4′-C-methoxy-β-d-arabinouridine (7)

To a mixture of compound 6 (400 mg, 1.45 mmol) in 10 mL of anhydrous pyridine, DMTrCl (740 mg, 2.18 mmol) was added under nitrogen atmosphere. The reaction mixture was stirred at room temperature for 12 h and quenched with MeOH. The resulting reaction mixture was concentrated in vacuo, diluted with EtOAc, washed with water and brine, dried over Na2SO4, and concentrated in vacuo. The residue was purified by flash chromatography (gradient eluent: MeOH/DCM, 0–5% v/v) to afford target compound 7 as a white foam, yield 81%. 1H-NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.1 Hz, 1H, H-6), 7.39–7.26 (m, 9H, Ar–H), 6.85 (m, 4H, Ar–H), 6.11 (d, J = 17.8 Hz, 1H, H-1′), 5.32 (d, J = 8.1 Hz, 1H, H-5), 4.92 (dd, J = 53.0, 5.6 Hz, 1H, H-2′), 4.71 (dd, J = 21.8, 5.5 Hz, 1H, H-3′), 3.80 (d, J = 1.4 Hz, 6H, 2 × –OCH3), 3.56 (d, J = 10.1 Hz, 1H, Ha-5′), 3.38 (d, J = 10.1 Hz, 1H, Hb-5′), 3.24 (s, 3H, –OCH3); ESI-MS (m/z) 601.2 [M + Na]+.

4.1.7. 2′-Deoxy-5′-O-(4,4′-dimethoxy)trityl-4′-C-methoxy-β-d-arabinouridine-3′-O-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite (8)

Under nitrogen atmosphere, 5′-O-DMTr compound 7 (400 mg, 0.69 mmol) was dissolved in anhydrous CH2Cl2; then, 1H-tetrazole (70 mg, 0.83 mmol) was added followed by 2-cyanoethyl-N,N,N′,N′-tetraisopropyl)phosphoramidite (375 mg, 1.04 mmol). The reaction mixture was stirred at room temperature for 3 h. The resulting mixture was extracted with CH2Cl2, washed with saturated NaHCO3 solution, dried over MgSO4, and concentrated in vacuo. The residue was purified by flash chromatography (gradient eluent: MeOH/DCM, 0–5% v/v) to afford phosphoramidite 8 as a white foam, yield 74%. 31P-NMR (162 MHz, DMSO-d6) δ 151.76, 151.43. 19F-NMR (376 MHz, DMSO-d6) δ −197.10, −197.75; ESI-MS (m/z) 801.3 [M + Na]+.

4.1.8. Oligonucleotide Synthesis

RNA was purchased from Guangzhou RiboBio Inc. The syntheses of other ONs used in this study were performed on an automated synthesizer (K&A H-8) using the standard solid-phase phosphoramidate protocol. Each oligonucleotide was synthesized at the 1-μmol scale using T-CPG support. All DNA phosphoramidites were prepared as 0.11 M solutions in acetonitrile (ACN) except the modified monomers as 0.15 M in ACN. Furthermore, 0.3 M 5-ethylthio-1H-tetrazole (ETT) in ACN was used as the activator, 3% dichloroacetic (DCA) acid in DCM was used to detritylate, acetic anhydride + lutidine (Cap A) and 1-methylimidazole (Cap B) in THF were used to cap, and 0.1 M I2 in THF/Py/H2O (80:40:2, v/v) was used for oxidation. The coupling time was extended to 6 min for the incorporation of the modified analogs. Cleavage from the solid support and removal of the protecting groups were accomplished using concentrated ammonium hydroxide solution (28% NH3 aq.) at 55 °C for 8–12 h. The crude oligonucleotides were purified by reverse-phase HPLC with a Kromasil 100-5C18 (250 mm × 4.6 mm) column (buffer A: 100 Mm hexafluoroisopropanol (HFIP), 31.6 mM triethylamine (TEA), 10% v/v MeOH; buffer B: MeOH). The obtained pure fractions were analyzed for purity by HPLC chromatography, quantified by UV absorbance at 260 nm, and confirmed by MALDI-TOF or ESI mass spectrometry.

4.2. Ultraviolet (UV) Melting Experiments

UV melting experiments were carried out by mixing equimolecular amounts of ONs with DNA or RNA complement in 10 mM sodium phosphate buffer (pH 7.2) containing 100 mM NaCl to give a final concentration of 4 μM. The samples were annealed by heating at 95 °C for 5 min followed by slow cooling to room temperature. Absorbance was recorded at 260 nm from 15–90 °C at a rate of 1 °C/min. The melting temperatures (Tm) were calculated as the first-derivative maximum of the melting curve, and determined by averaging at least three independent measurements, which were accurate within ±1 °C.

4.3. Circular Dichroism Spectroscopy

CD spectra were recorded three times independently at 20 °C at a rate of 50 nm/min from 200–320 nm. The cell path length was 0.1 cm. The duplex nucleic-acid concentration used was 4 μM, and the samples were prepared in the same method described in the UV melting experiments.

4.4. Nuclease Stability Experiments

Degradation of oligonucleotides (0.0175 nM) by snake venom phosphodiesterase (SVPDE; 0.02 μg/mL) was performed in a buffer (pH 8.0) containing 10 mM MgCl2, 50 mM Tris-HCl at 37 °C. Aliquots were taken at several time points and quenched by methanol to deactivate the nuclease. The timed reaction mixtures were analyzed by HPLC to evaluate the amount of intact oligonucleotides remaining. The percentage of intact oligonucleotide in each sample was calculated and plotted against the time of exposure to get the oligonucleotide degradation profile with time.

Supplementary Materials

The following are available online: Table S1: The mass spectra data and HPLC purity of modified oligonucleotides; Table S2: 1H–1H and 1H–19F coupling constant values for 2′-F,4′-C-OMe–araU and 2′-F–araU; NMR spectra of intermediates and phosphoramidite; HPLC charts and MS spectra of modified oligonucleotides.

Author Contributions

X.-Y.H.: conceptualization, funding acquisition, project administration, methodology, data curation, formal analysis, validation, writing original draft, reviewing and editon; J.W.: methodology, data curation, formal analysis and validation; D.-D.L.: methodology, data curation, formal analysis, funding acquisition; S.-Q.W.: conceptualization, funding acquisition, supervision and project administration. All authors approved the final version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (Grant No 81402841) and the Special Key Project of China (Grant No. 2017ZX09303013-003).

Acknowledgments

The authors would like to express their sincere gratitude to Xin-Xiu Deng for their excellent technical support for oligonucleotide purification and analysis.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Deleavey, G.F.; Damha, M.J. Designing chemically modified oligonucleotides for targeted gene silencing. Chem. Biol. 2012, 19, 937–954. [Google Scholar] [PubMed]
  2. Burnett, J.C.; Rossi, J.J. RNA-based therapeutics: Current progress and future prospects. Chem. Biol. 2012, 19, 60–71. [Google Scholar] [PubMed]
  3. Dirin, M.; Winkler, J. Influence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides. Expert Opin. Biol. Ther. 2013, 13, 875–888. [Google Scholar] [CrossRef] [PubMed]
  4. Østergaard, M.E.; Dwight, T.; Berdeja, A.; Swayze, E.E.; Jung, M.E.; Seth, P.P. Comparison of duplex stabilizing properties of 2′-fluorinated nucleic acid analogues with furanose and non-Furanose sugar rings. J. Org. Chem. 2014, 79, 8877–8881. [Google Scholar] [CrossRef] [PubMed]
  5. Ellipilli, S.; Ganesh, K.N. Fluorous peptide nucleic acids: PNA analogues with fluorine in backbone (γ-CF2-apg-PNA) enhance cellular uptake. J. Org. Chem. 2015, 80, 9185–9191. [Google Scholar] [PubMed]
  6. Dugovic, B.; Leumann, C.J. A 6′-fluoro-substituent in bicyclo-DNA increases affinity to complementary RNA presumably by CF–HC pseudohydrogen bonds. J. Org. Chem. 2014, 79, 1271–1279. [Google Scholar] [CrossRef] [PubMed]
  7. Hagmann, W.K. The many roles for fluorine in medicinal chemistry. J. Med. Chem. 2008, 51, 4359–4369. [Google Scholar] [CrossRef] [PubMed]
  8. Martínpintado, N.; Yahyaeeanzahaee, M.; Deleavey, G.F.; Portella, G.; Orozco, M.; Damha, M.J.; González, C. Dramatic effect of furanose C2′ substitution on structure and stability: Directing the folding of the human telomeric quadruplex with a single fluorine atom. J. Am. Chem. Soc. 2013, 135, 5344–5347. [Google Scholar]
  9. Anzahaee, M.Y.; Watts, J.K.; Alla, N.R.; Nicholson, A.W.; Damha, M.J. Energetically important C-H⋯F-C pseudohydrogen bonding in water: Evidence and application to rational design of oligonucleotides with high binding affinity. J. Am. Chem. Soc. 2011, 133, 728–731. [Google Scholar] [PubMed]
  10. Gore, K.R.; Harikrishna, S.; Pradeepkumar, P. Influence of 2′-Fluoro versus 2′-O-Methyl Substituent on the Sugar Puckering of 4′-C-Aminomethyluridine. J. Org. Chem. 2013, 78, 9956–9962. [Google Scholar] [PubMed]
  11. Watts, J.K.; Choubdar, N.; Sadalapure, K.; Robert, F.; Wahba, A.S.; Pelletier, J.; Pinto, B.M.; Damha, M.J. 2′-Fluoro-4′-thioarabino-modified oligonucleotides: Conformational switches linked to siRNA activity. Nucleic Acids Res. 2007, 35, 1441–1451. [Google Scholar] [CrossRef] [PubMed]
  12. Watts, J.K.; Damha, M.J. 2′F-Arabinonucleic acids (2′F-ANA)-history, properties, and new frontiers. Can. J. Chem. 2008, 86, 641–656. [Google Scholar] [CrossRef]
  13. Watts, J.K.; Martínpintado, N.; Gómezpinto, I.; Schwartzentruber, J.; Portella, G.; Orozco, M.; González, C.; Damha, M.J. Differential stability of 2′F-ANARNA and ANARNA hybrid duplexes: Roles of structure, pseudohydrogen bonding, hydration, ion uptake and flexibility. Nucleic Acids Res. 2010, 38, 2498–2511. [Google Scholar] [CrossRef] [PubMed]
  14. Martínpintado, N.; Yahyaeeanzahaee, M.; Camposolivas, R.; Noronha, A.M.; Wilds, C.J.; Damha, M.J.; González, C. The solution structure of double helical arabino nucleic acids (ANA and 2′F-ANA): Effect of arabinoses in duplex-hairpin interconversion. Nucleic Acids Res. 2012, 40, 9329–9339. [Google Scholar] [CrossRef] [PubMed]
  15. Liboska, R.; Snášel, J.; Barvík, I.; Buděšínský, M.; Pohl, R.; Točík, Z.; Páv, O.; Rejman, D.; Novák, P.; Rosenberg, I. 4′-Alkoxy oligodeoxynucleotides: A novel class of RNA mimics. Org. Biomol. Chem. 2011, 9, 8261–8267. [Google Scholar] [CrossRef] [PubMed]
  16. Petrová, M.; Páv, O.; Buděšínský, M.; Zborníková, E.; Novák, P.; Rosenbergová, Š.; Pačes, O.; Liboska, R.; Dvořáková, I.; Simak, O.; et al. Straightforward synthesis of purine 4′-alkoxy-2′-deoxynucleosides: First report of mixed purine-pyrimidine 4′-alkoxyoligodeoxynucleotides as new RNA mimics. Org. Lett. 2015, 17, 3426–3429. [Google Scholar] [CrossRef] [PubMed]
  17. Martinezmontero, S.; Deleavey, G.F.; Dierkerviik, A.; Lindovska, P.; Ilina, T.; Portella, G.; Orozco, M.; Parniak, M.A.; González, C.; Damha, M.J. Synthesis and properties of 2′-Deoxy-2′,4′-difluoroarabinose modified nucleic acids (2′,4′-diFANA). J. Org. Chem. 2015, 80, 3083–3091. [Google Scholar] [CrossRef] [PubMed]
  18. Gore, K.R.; Nawale, G.N.; Harikrishna, S.; Chittoor, V.G.; Pandey, S.K.; Höbartner, C.; Patankar, S.; Pradeepkumar, P.I. Synthesis, gene silencing, and molecular modeling studies of 4′-C-aminomethyl-2′-O-methyl modified small interfering RNAs. J. Org. Chem. 2012, 77, 3233–3245. [Google Scholar] [CrossRef] [PubMed]
  19. Malek-Adamian, E.; Guenther, D.C.; Matsuda, S.; Martínez-Montero, S.; Zlatev, I.; Harp, J.; Burai Patrascu, M.; Foster, D.J.; Fakhoury, J.; Perkins, L.; et al. 4′-C-Methoxy-2′-deoxy-2′-fluoro modified ribonucleotides improve metabolic stability and elicit efficient RNAi-mediated gene silencing. J. Am. Chem. Soc. 2017, 139, 14542–14555. [Google Scholar] [CrossRef] [PubMed]
  20. Ma, W.; Wang, J.; Lu, D.-D.; Yang, J.; Qin, B.-J.; He, X.-Y.; Wang, S.-Q. Synthesis and antisense properties of 2′-β-F- and 2′-α-F-2′-deoxy-uridines modified oligonucleotides with 4′-C-(2-methoxyethoxy) substituent. Acta Pharm. Sin. 2016, 51, 1271–1280. [Google Scholar]
  21. Wang, G.; Deval, J.; Hong, J.; Dyatkina, N.; Prhavc, M.; Taylor, J.; Fung, A.; Jin, Z.; Stevens, S.K.; Serebryany, V. Discovery of 4′-chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection. J. Med. Chem. 2015, 58, 1862–1878. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the compounds are not available from the authors.
Figure 1. Structure of fluorinated nucleotide 2′-F–arabinonucleic acid (ANA), 2′-F–RNA, selected 4′-substituted 2′-F–ANA derivatives, and 2′-F,4′-C-OMe–arabinouridine (araU) designed in the present study. B = nucleobase, U = uracil-1-yl.
Figure 1. Structure of fluorinated nucleotide 2′-F–arabinonucleic acid (ANA), 2′-F–RNA, selected 4′-substituted 2′-F–ANA derivatives, and 2′-F,4′-C-OMe–arabinouridine (araU) designed in the present study. B = nucleobase, U = uracil-1-yl.
Molecules 23 02374 g001
Scheme 1. The general synthesis procedure of 2′-F,4′-C-OMe–araU phosphoramidite 8. Reagents and conditions: (i) imidazole, Ph3P, I2, tetrahydrofuran (THF), 0 °C–room temperature (rt), 4 h, 78%; (ii) NaOMe–MeOH, reflux, 3 h, 85%; (iii) methanol, PbCO3, I2, THF (dry), 0 °C–rt, 3 h, 90%; (iv) benzoyl chloride (BzCl), pyridine (dry), dichloromethane (DCM), 0 °C–rt, 3 h, 95%; (v) (a) m-chloroperbenzoic acid (m-CPBA), DCM/H2O, 0 °C–rt, 3 h, (b) NH3–MeOH, rt, 12 h, 64% two steps; (vi) dimethoxytrityl chloride (DMTrCl), pyridine (dry), rt, 12 h, 81%; (vii) 2-cyanoethyl N,N,N′,N′-tetraisopropylphosphoramidite, 1H-tetrazole, DCM (dry), room temperature, 3 h, 74%.
Scheme 1. The general synthesis procedure of 2′-F,4′-C-OMe–araU phosphoramidite 8. Reagents and conditions: (i) imidazole, Ph3P, I2, tetrahydrofuran (THF), 0 °C–room temperature (rt), 4 h, 78%; (ii) NaOMe–MeOH, reflux, 3 h, 85%; (iii) methanol, PbCO3, I2, THF (dry), 0 °C–rt, 3 h, 90%; (iv) benzoyl chloride (BzCl), pyridine (dry), dichloromethane (DCM), 0 °C–rt, 3 h, 95%; (v) (a) m-chloroperbenzoic acid (m-CPBA), DCM/H2O, 0 °C–rt, 3 h, (b) NH3–MeOH, rt, 12 h, 64% two steps; (vi) dimethoxytrityl chloride (DMTrCl), pyridine (dry), rt, 12 h, 81%; (vii) 2-cyanoethyl N,N,N′,N′-tetraisopropylphosphoramidite, 1H-tetrazole, DCM (dry), room temperature, 3 h, 74%.
Molecules 23 02374 sch001
Figure 2. The circular dichroism (CD) spectra of duplexes formed by the modified oligonucleotides ON2ON5 with RNA complements. Spectra were recorded three times independently at 20 °C after annealing the duplexes under the same condition described in ultraviolet (UV) melting experiments.
Figure 2. The circular dichroism (CD) spectra of duplexes formed by the modified oligonucleotides ON2ON5 with RNA complements. Spectra were recorded three times independently at 20 °C after annealing the duplexes under the same condition described in ultraviolet (UV) melting experiments.
Molecules 23 02374 g002
Figure 3. Enzymatic stability of 5′–d(TTTTTTTTUT)–3′ against snake venom phosphodiesterase (SVPDE). U = 2′-F,4′-C-OMe–araU (X, ON12, cross), 2′-F–araU (Z, ON13, triangle), 3′-phosphorothioate-T (Ts, ON14, rectangle), and natural DNA–dT (ON15, diamond). Degradation of oligonucleotides (17.5 pM) by SVPDE (0.02 μg/mL) was performed in a buffer (pH 8.0) containing 10 mM MgCl2, 50 mM Tris-HCl at 37 °C.
Figure 3. Enzymatic stability of 5′–d(TTTTTTTTUT)–3′ against snake venom phosphodiesterase (SVPDE). U = 2′-F,4′-C-OMe–araU (X, ON12, cross), 2′-F–araU (Z, ON13, triangle), 3′-phosphorothioate-T (Ts, ON14, rectangle), and natural DNA–dT (ON15, diamond). Degradation of oligonucleotides (17.5 pM) by SVPDE (0.02 μg/mL) was performed in a buffer (pH 8.0) containing 10 mM MgCl2, 50 mM Tris-HCl at 37 °C.
Molecules 23 02374 g003
Table 1. Melting temperature (Tm) values (°C) of the duplexes formed by 2′-F,4′-C-OMe–arabinouridine (araU) (X) and 2′-F–araU (Y) modified DNA with their complementary single-stranded DNA and RNA (ssDNA and ssRNA) a. ON—oligonucleotide.
Table 1. Melting temperature (Tm) values (°C) of the duplexes formed by 2′-F,4′-C-OMe–arabinouridine (araU) (X) and 2′-F–araU (Y) modified DNA with their complementary single-stranded DNA and RNA (ssDNA and ssRNA) a. ON—oligonucleotide.
#Sequence (5′–3′)ssRNAssDNARNA Selectivity
TmΔTmTmΔTm bΔTm (RNA) − ΔTm (DNA)
ON1GCGTTTTTTGCT47.5 51.7
ON2GCGTTXTTTGCT47.0−0.548.4−3.32.8
ON3GCGTTYTTTGCT46.3−1.251.2−0.5−0.7
ON4GCGTTXTXTGCT46.3−1.246.1−5.64.4
ON5GCGXTXTXTGCT42.9−4.6ND c
ON6GCGTTGTTTGCT50.4 56.6
ON7GCGTXGTTTGCT52.01.652.5−4.15.7
ON8GCGTTGXTTGCT49.5−0.951.2−5.44.5
ON9GCGTTATTTGCT45.6 51.3
ON10GCGTXATTTGCT48.22.647.9−3.46.0
ON11GCGTTAXTTGCT44.6−1.046.5−4.83.7
a The ultraviolet (UV) melting experiments were carried out in 10 mM sodium phosphate buffer (pH 7.2) containing 100 mM NaCl at a rate of 1 °C/min at 260 nm. The concentration of the oligonucleotide was 4 μM for each strand. The sequences of target DNA and RNA complements were 5′–d(AGCAAAAAACGC)–3′ and 5′–r(AGCAAAAAACGC)–3′ for ON1ON5, 5′–d(AGCAAACAACGC)–3′ and 5′–r(AGCAAACAACGC)–3′ for ON6ON8, and 5′–d(AGCAAATAACGC)–3′ and 5′–r(AGCAAAUAACGC)–3′ for ON9ON11. b ΔTm = Tm(modified)Tm(unmodified); c ND: not determined as typical “S”-shape melting curve was not formed.

Share and Cite

MDPI and ACS Style

He, X.-Y.; Wang, J.; Lu, D.-D.; Wang, S.-Q. Synthesis and Antisense Properties of 2′β-F-Arabinouridine Modified Oligonucleotides with 4′-C-OMe Substituent. Molecules 2018, 23, 2374. https://doi.org/10.3390/molecules23092374

AMA Style

He X-Y, Wang J, Lu D-D, Wang S-Q. Synthesis and Antisense Properties of 2′β-F-Arabinouridine Modified Oligonucleotides with 4′-C-OMe Substituent. Molecules. 2018; 23(9):2374. https://doi.org/10.3390/molecules23092374

Chicago/Turabian Style

He, Xiao-Yang, Jing Wang, Dan-Dan Lu, and Sheng-Qi Wang. 2018. "Synthesis and Antisense Properties of 2′β-F-Arabinouridine Modified Oligonucleotides with 4′-C-OMe Substituent" Molecules 23, no. 9: 2374. https://doi.org/10.3390/molecules23092374

APA Style

He, X. -Y., Wang, J., Lu, D. -D., & Wang, S. -Q. (2018). Synthesis and Antisense Properties of 2′β-F-Arabinouridine Modified Oligonucleotides with 4′-C-OMe Substituent. Molecules, 23(9), 2374. https://doi.org/10.3390/molecules23092374

Article Metrics

Back to TopTop